To the Editor, After an outbreak of unexplained pneumonia cases in Wuhan, China in December 2019, the World Health Organization (WHO) officially named the disease caused by the culprit virus as Coronavirus Disease 2019 (COVID-19). 1 Faced with a global public health emergency, dermatology practices are now using telemedicine to limit in-person appointments to reduce transmission of COVID-19 per interim guidance from the Centers for Disease Control (CDC) and the American Academy of Dermatology (AAD). 2 A recent letter to the editor likewise recommends minimizing trainee exposure to maintain a potential pool of residents to supplement the growing need for hospital staff. 3 While some dermatology residents will eventually be deployed to treat COVID-19 patients in overloaded hospital systems, most dermatology residents are currently working in dermatology clinics impacted by this pandemic. The Accreditation Counsel for Graduate Medical Education's (ACGME) clinical and educational expectations are such that significant changes in resident/fellow education of more than four weeks in duration must be reported to the Executive Director of the applicable Review Committee. 4 Training disruptions caused by the implementation of telemedicine and altered clinic workflow may affect resident board eligibility and compromise dermatology resident education. Preservation of resident education during this pandemic is essential.
Epic, an electronic medical record software application, is utilized at our institution as well as many other academic centers. The Epic Haiku application can be utilized on smartphones to perform virtual video visits which will allow many institutions to transition to teledermatology. Epic Haiku features a "multi-provider" video visit option whereby multiple providers can simultaneously interface with the patient from distinct and remote locations. There
